A functional interaction between RHA and Ubc9, an E2-like enzyme specific for Sumo-1

Journal of Molecular Biology

Volumn 341, Issue 1, 2004, Pages 15-25

  Argasinska, Joanna ^a   Zhou, Kai ^a   Donnelly, Robert J ^a   Hay, Ronald T ^b   Lee, Chee Gun ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

CREB; CREB, cAMP responsive element binding protein; DTT, dithiothreitol; maleless; MLE, maleless; MSL, male specific lethal; NEM, N ethyl maleimide; RHA, RNA helicase A; RNA helicase A; SAE, Sumo 1 activating enzyme; Sumo 1; Ubc9

Indexed keywords

AMINO ACID; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; PROTEIN UBC9; RNA HELICASE; SUMO 1 PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CATALYSIS; CONJUGATION; CONTROLLED STUDY; EMBRYO; ENZYME SPECIFICITY; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

EID: 4143087119     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2004.06.004     Document Type: Article

References (55)

1. Lee C.G., Hurwitz J. A new RNA helicase isolated from HeLa cells that catalytically translocates in the 3′ to 5′ direction. J. Biol. Chem. 267:1992;4398-4407
2. Zhang S., Grosse F. Nuclear DNA helicase II unwinds both DNA and RNA. Biochemistry. 33:1994;3906-3912
3. Lee C.G., Hurwitz J. Human RNA helicase A is homologous to the maleless protein of Drosophila. J. Biol. Chem. 268:1993;16822-16830
4. Richter L., Bone J.R., Kuroda M.I. RNA-dependent association of the Drosophila maleless protein with the male X chromosome. Genes Cells. 1:1996;325-336
5. Maroni G., Plaut W. Dosage compensation in Drosophila melanogaster triploids. I. Autoradiographic study. Chromosoma. 40:1973;361-377
6. Baker B.S., Gorman M., Marin I. Dosage compensation in Drosophila. Annu. Rev. Genet. 28:1994;491-521
7. Kelley R.L., Kuroda M.I. Equility for X chromosome. Science. 270:1995;1607-1610
8. Pannuti A., Lucchesi J.C. Recycling to remodel: evolution of dosage-compensation complexes. Curr. Opin. Genet. Dev. 10:2000;644-650
9. Kelley R.L., Kuroda M.I. Noncoding RNA genes in dosage compensation and imprinting. Cell. 103:2000;9-12
10. Lee C.G., Chang K.A., Kuroda M.I., Hurwitz J. The NTPase/helicase activities of Drosophila maleless, an essential factor in dosage compensation. EMBO J. 16:1997;2671-2681
11. Kuroda M.I., Kernan M.J., Kreber R., Ganetzky B., Baker B.S. The maleless protein associates with the X chromosome to regulate dosage compensation in Drosophila. Cell. 66:1991;935-947
12. Lee C.G., Soares V.C., Newberger C., Manova K., Lacy E., Hurwitz J. RNA helicase A is essential for normal gastrulation. Proc. Natl Acad. Sci. USA. 95:1998;13709-13713
13. Lee C.G., Eki T., Okumura K., Soares V., Hurwitz J. Molecular analysis of the cDNA and genomic DNA encoding mouse RNA helicase A. Genomics. 47:1998;365-371
14. Reddy T.R., Tang H., Weidong X., Wong-Staal F. Sam68, RNA helicase A and Tap cooperate in the post-transcriptional regulation of human immunodeficiency virus and type D retroviral mRNA. Oncogene. 19:2000;3570-3575
15. Li J., Tang H., Mullen T.M., Westberg C., Reddy T.R., Rose D.W., Wong-Staal F. A role for RNA helicase A in post-transcriptional regulation of HIV type 1. Proc. Natl Acad. Sci. USA. 96:1999;709-714
16. Nakajima T., Uchida C., Anderson S.F., Lee C.G., Hurwitz J., Parvin J.D., Montminy M. RNA helicase A mediates association of CBP with RNA polymerase II. Cell. 90:1997;1107-1112
17. Anderson S.F., Schlegel B.P., Nakajima T., Wolpin E.S., Parvin J.D. BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A. Nature Genet. 19:1998;254-256
18. Schlegel B.P., Starita L.M., Parvin J.D. Ocerexpression of a protein fragment of RNA helicase A causes inhibition of endogenous BRCA1 function and defects in ploidy and cytokinesis in mammary epithelial cells. Oncogene. 22:2003;983-991
19. Liao H.J., Kobayashi R., Mathews M.B. Activities of adenovirus virus-associated RNAs: purification and characterization of RNA binding proteins. Proc. Natl Acad. Sci. USA. 95:1998;8514-8519
20. Pellizzoni L., Charroux B., Rappsilber J., Mann M., Dreyfuss G. A functional interaction between the survival motor neuron complex and RNA polymerase II. J. Cell Biol. 152:2001;75-86
21. Lee C.G., Hague L.K., Li H., Donnelley R. Identification of toposome, a novel multisubunit complex containing topoisomerase IIα Cell Cycle. 3:2004;638-647
22. Zhou K., Choe K.T., Zaidi Z., Wang Q., Mathews M.B., Lee C.G. RNA helicase A interacts with dsDNA and topoisomerase IIα Nucl. Acids Res. 31:2003;2253-2260
23. Meller V.H., Gordadze P.R., Park Y., Chu X., Stuckenholz C., Kelley R.L., Kuroda M.I. Ordered assembly of roX RNAs into MSL complexes on the dosage compensated X chromosome in Drosophila. Curr. Biol. 10:2000;136-143
24. Fujii R., Okamoto M., Aratani S., Oishi T., Ohshima T., Taira K., et al. A role of RNA helicase A in cis-acting transactivation response element-mediated transcriptional regulation of human immunodeficiency virus type 1. J. Biol. Chem. 276:2001;5445-5451
25. Hateboer G., Hijmans E.M., Nooij J.B.D., Schlenker S., Jentsch S., Bernards R. mUBC9, a novel adenovirus E1A-interacting protein that complements a yeast cell cycle defect. J. Biol. Chem. 271:1996;25906-25911
26. Desterro J.M.P., Thomson J., Hay R.T. Ubch9 conjugates Sumo but not ubiquitin. FEBS Letters. 417:1997;297-300
27. Desterro J.M.P., Rodriguez M.S., Kemp G.D., Hay R.T. Identification of the enzyme required for activation of the small ubiquitin-like protein Sumo-1. J. Biol. Chem. 274:1999;10618-10624
28. Mahajan R., Delphin C., Guan T., Gerace L., Melchior F. A small ubiquitin-related polypeptide involved in targeting ranGAP1 to nuclear pore complex protein RanBP2. Cell. 88:1997;97-107
29. Firestein R., Feuerstein N. Association of activating transcription factor 2 (ATF2) with the ubiquitin-conjugating enzyme hUBC9. Implication of the ubiquitin/proteasome pathway in regulation of ATF2 in T cells. J. Biol. Chem. 273:1998;5892-5902
30. Duprez E., Saurin A., Desterro J., Lallemand-Breitenbach V., Howe K., Boddy M., et al. Sumo-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation. J. Cell Sci. 112:1999;381-393
31. Rodriguez M.S., Desterro J.M.P., Lain S., Midgley C.A., Lane D.P., Hay R.T. SUMO-1 modification activates the transcriptional response of p53. EMBO J. 18:1999;6455-6461
32. Gostissa M., Hengstermann A., Fogal V., Sandy P., Schwarz S.E., Scheffner M., Del Sal G. Activation of p53 by conjugation to the ubiquitin-like protein Sumo-1. EMBO J. 18:1999;6462-6471
33. Sternsdorf T., Jensen K., Reich B., Will H. The nuclear dot protein Sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers. J. Biol. Chem. 274:1999;12555-12566
34. Desterro J.M., Rodriguez M.S., Hay R.T. Sumo-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol. Cell. 2:1998;233-239
35. Kim K.I., Baek S.H., Jeon Y.J., Nishimori S., Suzuki T., Uchida S., et al. A new Sumo-1-specific protease, SUSP1, that is highly expressed in reproductive organs. J. Biol. Chem. 275:2000;14102-14106
36. Kawabe Y.I., Seki M., Seki T., Wang W.S., Imamura O., Furuichi Y., et al. Covalent modification of the Werner's syndrome gene product with the ubiquitin-related protein, Sumo-1. J. Biol. Chem. 275:2000;20963-20966
37. Mao Y., Desai S.D., Liu L.F. Sumo-1 conjugation to human DNA topoisomerase II isozymes. J. Biol. Chem. 275:2000;26066-26073
38. Mao Y., Sun M., Desai S.D., Liu L.F. Sumo-1 conjugation to topoisomerase I: a possible repair response to topoisomerase-mediated DNA damage. Proc. Natl Acad. Sci. USA. 97:2000;4046-4051
39. Kao P., Chen L., Brock G., Ng J., Kenny J., Smith A., Corthesy B. Cloning and expression of cyclosporin A- and FK506-sensitive nuclear factor of activated T-cells: NF45 and NF90. J. Biol. Chem. 269:1994;20691-20699
40. Moilanen A.-M., Karvonen U., Poukka H., Yan W., Toppari J., Janne O.A., Palvimo J.J. A testis-specific androgen receptor coregulator that belongs to a novel family of nuclear proteins. J. Biol. Chem. 274:1999;3700-3704
41. Wu L., Wu H., Ma L., Sangiorgi F., Wu N., Bell J.R., Lyons G.E., Maxson R. Miz1, a novel zinc finger transcription factor that interacts with Msx2 and enhances its affinity for DNA. Mech. Dev. 65:1997;3-17
42. Kahyo T., Nishida T., Yasuda H. Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol. Cell. 8:2001;713-718
43. Liu B., Liao J., Rao X., Kushner S.A., Chung C.D., Chang D.D., Shuai K. Inhibition of Stat1-mediated gene activation by PIAS1. Proc. Natl Acad. Sci. USA. 95:1998;10626-10631
44. Yasugi T., Howley P.M. Identification of the structural and functional human homolog of the yeast ubiquitin-conjugating enzyme Ubc9. Nucl. Acids Res. 24:1996;2005-2010
45. Matunis M.J., Wu J., Blobel G. Sumo-1 modification and its role in targeting the Ran GTPase-activating protein, RanGAP1, to the nuclear pore complex. J. Cell Biol. 140:1998;499-509
46. Gong L., Millas S., Maul G.G., Yeh E.T.H. Differential regulation of sentrinized proteins by a novel sentrin-specific protease. J. Biol. Chem. 275:2000;3355-3359
47. Kovalenko O.V., Plug A.W., Haaf T., Gonda D.K., Ashley T., Ward D.C., Radding C.M., Golub E.I. Mammalian ubiquitin-conjugating enzyme Ubc9 interacts with Rad51 recombination protein and localizes in synaptonemal complexes. Proc. Natl Acad. Sci. USA. 93:1996;2958-2963
48. Kamitani T., Kito K., Nguyen H.P., Wada H., Fukuda-Kamitani T., Yeh E.T.H. Identification of three major sentrinization sites in PML. J. Biol. Chem. 273:1998;26675-26682
49. Lee G.W., Melchior F., Matunis M.J., Mahajan R., Tian Q., Anderson P. Modification of Ran GTPase-activating protein by the small ubiquitin-related modifier Sumo-1 requires Ubc9, an E2-type ubiquitin-conjugating enzyme homologue. J. Biol. Chem. 273:1998;6503-6507
50. Kurtzman A.L., Schechter N. Ubc9 interacts with a nuclear localization signal and mediates nuclear localization of the paired-like homeobox protein Vsx-1 independent of Sumo-1 modification. Proc. Natl Acad. Sci. USA. 98:2001;5602-5607
51. Hofmann H., Floss S., Stamminger T. Covalent modification of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins Sumo-1 and hSMT3b. J. Virol. 74:2000;2510-2524
52. Yeh E.T.H., Gong L., Kamitani T. Ubiquitin-like proteins: new wines in new bottles. Gene. 248:2000;1-14
53. Poukka H., Karvonen U., Janne O.A., Palvimo J.J. Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (Sumo-1). Proc. Natl Acad. Sci. USA. 97:2000;14145-14150
54. Poukka H., Aarnisalo P., Karvonen U., Palvimo J.J., Janne O.A. Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription. J. Biol. Chem. 274:1999;19441-19446
55. Buschmann T., Lerner D., Lee C.G., Ronai Z. The Mdm-2 amino terminus is required for Mdm2 binding and SUMO-1 conjugation by the E2 SUMO-1 conjugating enzyme Ubc9. J. Biol. Chem. 276:2001;40389-40395